1993
DOI: 10.1007/bf00989969
|View full text |Cite
|
Sign up to set email alerts
|

Taking anti-depressant medications: Resistance, trial commitment, conversion, disenchantment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
45
0
3

Year Published

2002
2002
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(49 citation statements)
references
References 13 publications
1
45
0
3
Order By: Relevance
“…22 The present research contributes to the understanding of patient views on depression management by indicating the diversity of possible viewpoints, and the fluidity of these over time (as highlighted by Karp in his work on 'illness careers' in depression). 23,24 In line with the conclusions of previous qualitative studies on depression in primary care (for example, Gask et al 25 ), the present findings highlight the importance of patient and GP beliefs in influencing management. The research extends these previous findings by exploring the varying goals of GPs and patients for the management of depression in primary care, with implications for clinical practice as outlined below.…”
Section: Comparison With Existing Literaturesupporting
confidence: 80%
“…22 The present research contributes to the understanding of patient views on depression management by indicating the diversity of possible viewpoints, and the fluidity of these over time (as highlighted by Karp in his work on 'illness careers' in depression). 23,24 In line with the conclusions of previous qualitative studies on depression in primary care (for example, Gask et al 25 ), the present findings highlight the importance of patient and GP beliefs in influencing management. The research extends these previous findings by exploring the varying goals of GPs and patients for the management of depression in primary care, with implications for clinical practice as outlined below.…”
Section: Comparison With Existing Literaturesupporting
confidence: 80%
“…The next stage in the women's careers as SSRI users was one of conflict. As was also found among people suffering from depression (Karp, 1993(Karp, , 1994, a major issue in the process of being diagnosed and accepting the medicine in this study was being labeled a person with a stigmatizing emotional disorder. It further became clear that the women saw SSRIs as a "double" stigma because of the perceived risk of stigmatization from the reputation of the medicine as a "happiness pill" and the association with emotional illness, the former stigma.…”
Section: Discussionmentioning
confidence: 63%
“…Among users of tricyclic antidepressants, Karp (1993) found, "When taking the first tablet, a revision of one's biochemistry and one's self would begin." Helweg-Jørgensen and Hansen (2002) found a similar tendency among users of benzodiazepines.…”
Section: Discussionmentioning
confidence: 98%
“…11,12 This study expands this evidence by suggesting that the fear of being labelled in this way, and the resultant stigma mean that many people with depression initially seek help only when they have reached a crisis point and are thus often not in a position to make an informed decision about antidepressant medication. Many of the factors subsequently highlighted by patients here as influencing their decisions about medication have also been reported elsewhere, [13][14][15][16][17] and with evidence that patients' preferences change over time.…”
Section: Comparison With Existing Literaturementioning
confidence: 71%